Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors

Brain Research

Volumn 1067, Issue 1, 2006, Pages 164-169

  Yamauchi, Miki ^a   Miyara, Takako ^a   Matsushima, Tetsuya ^a   Imanishi, Taiichiro ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

5 HT2A receptor; Corticosterone; Fluvoxamine; m Chlorophenylpiperazine; Paroxetine; Rat

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CORTICOSTERONE; FLUVOXAMINE MALEATE; KETANSERIN TARTRATE; PAROXETINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR; FLUVOXAMINE; KETANSERIN;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DESENSITIZATION; DOSE RESPONSE; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SEROTONIN BLOOD LEVEL; STEROID RELEASE; ANIMAL; BLOOD; DRUG EFFECT; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CORTICOSTERONE; FLUVOXAMINE; KETANSERIN; PAROXETINE; RATS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS;

EID: 31144476933     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.10.075     Document Type: Article

References (46)

1. J.C. Alvarez, N. Gluck, I. Arnulf, P. Quintin, M. Leboyer, R. Pecquery, J.M. Launay, F. Perez-Diaz, and O. Spreux-Varoquaux Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine Clin. Pharmacol. Ther. 66 1999 617 624
2. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses Behav. Brain Res. 73 1996 277 280
3. G. Bagdy Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences Ann. N. Y. Acad. Sci. 851 1998 357 363
4. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci. 16 1995 105 110
5. L.S. Brady, P.W. Gold, M. Herkenham, A.B. Lynn, and H.J. Whitfield Jr. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications Brain Res. 572 1992 117 125
6. 2 receptor mRNA in rat frontal cortex J. Neurochem. 61 1993 1270 1276
7. 2 receptor function in the brain of the guinea pig Neuropharmacology 32 1993 249 256
8. A.E. Calogero, R. Bernardini, A.N. Margioris, G. Bagdy, W.T. Gallucci, P.J. Munson, L. Tamarkin, T.P. Tomai, L. Brady, and P.W. Gold Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami Peptides 10 1989 189 200
9. A.E. Calogero, G. Bagdy, K. Szemeredi, M.E. Tartaglia, P.W. Gold, and G.P. Chrousos Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat Endocrinology 126 1990 1888 1894
10. 2A receptors in depression J. Psychiatry Neurosci. 29 2004 252 265
11. S.J. Claes CRH, stress, and major depression: a psychobiological interplay Vitam. Horm. 69 2004 117 150
12. G.E. Duncan, D.J. Knapp, S.W. Carson, and G.R. Breese Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone J. Pharmacol. Exp Ther. 285 1998 579 587
13. 2C receptor levels in the rat Br. J. Pharmacol. 123 1998 1707 1715
14. 1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies Fundam. Clin. Pharmacol. 10 1996 16 27
15. 2B receptors Behav. Pharmacol. 12 2001 613 620
16. 2A receptor function by long-term imipramine treatment in endogenous depression Hum. Psychopharmacol. 19 2004 251 258
17. D.B. Goodnough, and G.B. Baker 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination J. Neurochem. 62 1994 2262 2268
18. 2A receptors by agonists and antagonists Brain Res. Bull. 56 2001 441 451
19. 2A receptor mediation of the HPA axis Neuropharmacology 42 2002 162 169
20. F. Holsboer, and N. Barden Antidepressants and hypothalamic-pituitary- adrenocortical regulation Endocr. Rev. 17 1996 187 205
21. T. Ishikane, T. Koyama, S. Matsubara, Y. Odagaki, R. Matsubara, and I. Yamashita Pharmacological properties of a new antidepressant, fluvoxamine (SME3110): effects on extracellular levels of monoamine in vivo and monoaminergic receptors in rat brain (in Japanese) Jpn. J. Neuropsychopharmacol. 16 1994 37 42
22. J.B. Jensen, D.S. Jessop, M.S. Harbuz, A. Mørk, C. Sánchez, and J.D. Mikkelsen Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats J. Neuroendocrinol. 11 1999 465 471
23. H. Jørgensen, U. Knigge, A. Kjaer, and J. Warberg Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds J. Neuroendocrinol. 11 1999 283 290
24. R.S. Kahn, and S. Wetzler m-Chlorophenylpiperazine as a probe of serotonin function Biol. Psychiatry 30 1991 1139 1166
25. A.J. Kennedy, E.L. Gibson, M.T. O'Connell, and G. Curzon Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP Psychopharmacology (Berlin) 113 1993 262 268
26. 2C/2B receptor function Neuropharmacology 33 1994 1581 1588
27. 2C receptor antagonist Neuropharmacology 36 1997 609 620
28. 2 receptors in the rat brain J. Psychiatry Neurosci. 19 1994 63 67
29. Z. Liposits, C. Phelix, and W.K. Paull Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study Histochemistry 86 1987 541 549
30. J. Maj, and E. Moryl Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations J. Neural Transm.: Gen. Sect. 88 1992 143 156
31. J. Maj, M. Bijak, M. Dziedzicka-Wasylewska, R. Rogoz, Z. Rogoz, G. Skuza, and T. Tokarski The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain Psychopharmacology (Berlin) 127 1996 73 82
32. 2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders Neuropsychopharmacology 28 2003 402 412
33. A. Marwah, P. Marwah, and H. Lardy Liquid chromatography-electrospray ionization mass spectrometric analysis of corticosterone in rat plasma using selected ion monitoring J. Chromatogr., B: Biomed. Sci. Appl. 757 2001 333 342
34. C.B. Nemeroff, and M.J. Owens Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis CNS Spectr. 9 2004 23 31
35. G.N. Pandey Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies Ann. N. Y. Acad. Sci. 836 1997 182 200
36. 3 and cAMP in brains from depressed violent suicide victims Neuropsychobiology 49 2004 189 195
37. E. Sanders-Bush, M. Breeding, K. Knoth, and M. Tsutsumi Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system Psychopharmacology (Berlin) 99 1989 64 69
38. J.P. Seibyl, J.H. Krystal, L.H. Price, S.W. Woods, C. D'Amico, G.R. Heninger, and D.S. Charney Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects Psychiatry Res. 38 1991 227 236
39. E. Sibille, Z. Sarnyai, D. Benjamin, J. Gal, H. Baker, and M. Toth Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice Mol. Pharmacol. 52 1997 1056 1063
40. H. Silver Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia Int. Clin. Psychopharmacol. 18 2003 305 313
41. J. Ulrichsen, J.S. Partilla, and E.M. Dax Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion Psychopharmacology (Berlin) 107 1992 229 235
42. H.M. van Praag Can stress cause depression? Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 2004 891 907
43. O.M. Wolkowitz, E.S. Epel, and V.I. Reus Stress hormone-related psychopathology: pathophysiological and treatment implications World J. Biol. Psychiatry 2 2001 115 143
44. Y.N. Wong, B.M. Chien, and A.P. D'Mello Analysis of corticosterone in rat plasma by high-performance liquid chromatography J. Chromatogr., B: Biomed. Sci. Appl. 661 1994 211 218
45. 2C receptor-mediated hypolocomotion in rats Pharmacol. Biochem. Behav. 78 2004 683 689
46. N. Yasui-Furukori, T. Kondo, K. Mihara, Y. Inoue, and S. Kaneko Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia Psychopharmacology (Berlin) 171 2004 223 227